Open Targets (@OpenTargets) header
Open Targets (@OpenTargets) profile picture

Public-private partnership using human genetics and genomics data for systematic drug target identification and prioritisation We're on Bluesky @opentargets.org

Hinxton, Cambridgeshire, UK
Joined March 2014
Photo by Open Targets (@OpenTargets)Photo by Open Targets (@OpenTargets)Photo by Open Targets (@OpenTargets)Photo by Open Targets (@OpenTargets)Photo by Open Targets (@OpenTargets)Photo by Open Targets (@OpenTargets)Photo by Open Targets (@OpenTargets)Photo by Open Targets (@OpenTargets)Photo by Open Targets (@OpenTargets)Photo by Open Targets (@OpenTargets)
Meet PEGASUS 🧬 A new community standard for reporting predicted effector genes. Making post-GWAS predictions more FAIR, comparable, and reusable across studies. Read the bioRxiv preprint: biorxiv.org/content/10.64898… #GWAS #Genomics #OpenScience
1
6
12
1,412
🤖 AI Club for Biomedicine: Building and Benchmarking Biological AI Tomorrow, Cambridge Join @AIClubBioMed as they welcome speakers Kyle Taylor (@GoogleDeepMind) and Francesco Carli (@emblebi and @OpenTargets) No need to register, just turn up! 🔗 milner.cam.ac.uk/ai-club
1
1
177
Open Targets retweeted
The @OpenTargets Platform spring 🌼 release is out — and this one marks the beginning of something we've been building towards for a while.
1
3
10
497
Open Targets retweeted
Excited to share our new work. Over the past decade, single-cell genomics has transformed our ability to map cellular systems. But a major question remains: Can we predict how perturbations reshape cellular trajectories over time? In 2018, we first showed that it is possible to predict cellular responses to perturbations — ranging from disease signals to chemical treatments — even in unseen contexts. In 2022, we introduced CPA (MSB 2022; NeurIPS 2022), extending this idea to predict responses to unseen chemical and genetic perturbations, including their combinations. Since then, the field of perturbation modeling has grown enormously. The community has pushed the space forward with many creative ideas and powerful models. It’s exciting to see how fast things are moving — even though many fundamental challenges remain. One of the biggest is that cells are not static. They move through trajectories during development, immune responses, and disease. Yet most current models still predict perturbation effects within a single state, rather than how early perturbations propagate across future states and reshape downstream outcomes. To address this, we developed PerturbGen, a trajectory-aware generative AI model that predicts how genetic perturbations reshape downstream cellular states. Huge credit to the people who made this work possible. Thanks to co-first authors @lifeisscience_5, @Adib_m_, @Tomo_Isobe, @Amirhossein Vahidi, @delshadveghari & Anthony Rostron. Special recognition to @lifeisscience_5 and @Adib_m_ for driving this work over the finish line. Grateful for our outstanding collaborators from @HaniffaLab, @BertieGottgens lab @GosiaTrynka and many others — a true cross-institute effort across @SCICambridge, @OpenTargets ,@sangerinstitute and @Cambridge_Uni.🎉 PerturbGen learns transcriptional dynamics across cellular trajectories. By introducing perturbations at an early source state, it can simulate how these effects propagate into future states along differentiation trajectories. Scaling this across genes enables the creation of dynamic in silico perturbation atlases — maps of how perturbations reshape biological trajectories over time. We explored this idea across three biological questions. First, in a human in vivo LPS immune challenge, PerturbGen predicted that perturbing a transient IL1B signal dampens downstream inflammatory programs in myeloid cells, with pathway changes reversing signatures observed in an independent IL-1β stimulation experiment. Second, in human hematopoiesis, PerturbGen predicted transcriptional responses to CRISPR transcription factor knockouts and enabled construction of perturbation atlases revealing lineage- and age-specific regulatory programs. These programs could also be linked to human genetics and blood diseases, including recapitulation of signatures associated with ETV6-related thrombocytopenia. Finally, we asked whether perturbation modeling could help improve complex tissue models. We built a dynamic perturbation atlas of human skin organoids to identify perturbations that could guideorganoid cells towardhuman fetal skin states. PerturbGen prioritized activation of Wnt signaling via GSK3β inhibition. Experimental validation confirmed the prediction: treatment with CHIR99021 induced stromal gene programs and shifted organoid fibroblasts toward transcriptional states observed in fetal skin stroma. Together, these results show how trajectory-aware perturbation modeling can connect gene perturbations to developmental programs, human genetics, disease mechanisms, and experimental interventions. More broadly, we think these point toward a future where single-cell atlases become predictive systems. As atlases expand across tissues, developmental windows, and modalities, models like PerturbGen could enable dynamic, virtual perturbation atlases— allowing us to simulate interventions, generate hypotheses, and design experiments before stepping into the lab. Preprint shorturl.at/EkisP Code github.com/Lotfollahi-lab/Pe… Excited to see how the community builds on this work.
2
47
2
179
17,253
Open Targets retweeted
🔬New Perturbation Catalogue update! With a redesigned interface, richer datasets and powerful analysis workflows, it’s now easier than ever to explore genetic perturbation data. ebi.ac.uk/perturbation-catal… #Bioinformatics #FunctionalGenomics @OpenTargets
1
3
11
1,294
Open Targets retweeted
🚀 Announcing the Official @OpenTargets MCP! We've partnered with @AnthropicAI to provide AI with seamless access to high-quality genetics and target-discovery data. Open for the entire community to accelerate therapeutic development blog.opentargets.org/officia…
2
19
91
7,118
🚀 We’re Hiring Postdocs! Machine Learning • AI for Science • Computational Biology Want to push the boundaries of ML and decode life at scale? Join our lab (@sangerinstitute @Cambridge_Uni ) working with computer scientists, clinicians, biologists & experimentalists to build next-gen AI for genomics, multi-omics & biological discovery. 📌 Focus areas: • Core ML & generative modeling • ML for genomics, spatial & single-cell data • Foundation models for biology • AI for women’s health (funded by @WellcomeLeap ) • AI for drug discovery (funded by @OpenTargets ) • Agentic AI for scientific reasoning 📍 Cambridge, UK 🕒 3-year fixed term | Hybrid ⏳ Deadline: 1 Feb 2026 If you’re passionate about ML + biology and want real impact on human health—apply here: 👉 lnkd.in/dgkvqhd2
1
8
1
43
5,337
🚨New preprint just dropped 🚨 medrxiv.org/content/10.1101/… The main output from my PhD is finally public and we’re SUPER excited about the findings! If you’re interested in what we learnt about IBD with a massive 700+ sample sc-eQTL dataset of the gut, read on!
1
7
1
18
1,881
Thrilled to share the latest preprint from my lab: medrxiv.org/content/10.1101/…. Co-led by @Tobioinformatic and @Bradleyomics, supervised by myself and @IBD_MB, we generated IBDverse💫 - gaining insights into genetic susceptibility and pathology of inflammatory bowel disease (IBD).
2
12
30
2,925
Open Targets retweeted
If EMBL-EBI data resources have saved you time & effort, now is your chance to give back! Fill in a 15-minute survey to help us: 🌍Demonstrate the real-world impact of these resources 🧠Understand your needs 🌟Secure continued funding Closes 16 July 👉 surveymonkey.com/r/QGFMBH8?c…]
21
5
39
12,241
Open Targets retweeted
There are many improvements and new features in the latest @OpenTargets release. Genetics here we go 🚀 New data visualizations, accessible color pallets, and full UI refresh. Not to say, the addition of @observablehq Plot.js s, the upgrade to @vite_js v6. React Router v7 🔜
1
1
7
520
New preprint from our group @emblebi and the @TVPLab ! We combined pseudotemporal ordering of cross sectional MASLD patient data with network analysis to describe the disease progression and identify a signature of 24 plasma biomarkers for patient staging biorxiv.org/content/10.1101/…
1
7
1
21
1,297
Less than a month to apply! If you're a PhD student in human genetics, don't miss this unique opportunity. We have a stellar lineup of tutors promising immersive scientific and mentoring discussions. – at Duxford, England
🌟 Exciting news: The Leena Peltonen School of Human Genetics returns in 2025! This prestigious summer school brings together leaders in human genetics with PhD students 📅 July 27-31, 2025 📍 Wellcome Genome Campus, UK 📝 Apply by March 7 at lpshg.com
7
14
1,970
🌟 Exciting news: The Leena Peltonen School of Human Genetics returns in 2025! This prestigious summer school brings together leaders in human genetics with PhD students 📅 July 27-31, 2025 📍 Wellcome Genome Campus, UK 📝 Apply by March 7 at lpshg.com – at Duxford, England
1
17
2
37
9,138
Open Targets retweeted
A great chance to come and join the Open-IBD team! 👇 @BSGTrainees
We have an amazing opportunity for someone to do a 3 year IBD focused data science PhD in Edinburgh as part of a fully funded OPEN-IBD fellowship. It’s a fantastic department, in a beautiful city, and the clinical commitment will be ~20% to recruit patients to OPEN IBD with the remaining time dedicated to doing the PhD. Full-time salary & PhD fees covered. Reach out to @JonnyBlackwell or me for an informal chat if interested. @EdinUni_IGC @EdinburghUni @NHS_Lothian @OpenIBD elxw.fa.em3.oraclecloud.com/…
10
19
2,403
This is a very exciting opportunity to join a project across @ewanbirney and @OpenTargets teams at @emblebi - apply now!
Got a PhD in bioinformatics or quantiative/CS degree? Want to work with AI on real world health care data, using some of the biggest datasets in the world? Want to live in Cambridge UK and work in European EMBL? This job in my research group is for you! embl.org/jobs/position/EBI02…
2
5
660
Thrilled to travelling to #ASHG2024 today! If you want to hear about how we can use large scale single cell RNA sequencing to better understand susceptibility to common complex diseases - drop by my talk on Wednesday!
8
1
27
1,939
Looking forward to sharing our #OpenTargets research from the @sangerinstitute 🧬 Illuminating therapeutic targets of neurodegeneration using genome-wide phenotypic CRISPR screens 🧠 on Wednesday at 14:00 in the Four Seasons Ballroom 2-3 at #ASHG24 #ASHG2024 #OpenTargetsAt10 !
1
3
18
2,499
Open Targets retweeted
Delighted to share our work in @NatureGenet using base editing to map genetic mechanisms of drug resistance. If you're interested in drug discovery then check it out. Access here rdcu.be/dXmlo [rdcu.be]. Congratulations to the team and @MatthewACoelho
2
13
34
5,868